Similar articles

• The prevalence of antiphospholipid antibodies in women with reproductive failure or major abruptio placentae.

  van der Spuy ZM, Bird AR, Lindow SW, Bruce C. van der Spuy ZM, et al. S Afr Med J. 1993 May;83(5):319-21. S Afr Med J. 1993. PMID: 8211423
• Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome.

  Branch DW, Silver R, Pierangeli S, van Leeuwen I, Harris EN. Branch DW, et al. Obstet Gynecol. 1997 Apr;89(4):549-55. doi: 10.1016/s0029-7844(97)00065-3. Obstet Gynecol. 1997. PMID: 9083311
• Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome.

  Rote NS. Rote NS. Obstet Gynecol. 1997 Oct;90(4 Pt 1):642-4. Obstet Gynecol. 1997. PMID: 9380335 No abstract available.
• Antiphospholipid syndrome in obstetrics and gynecology.

  Shapiro GA. Shapiro GA. Semin Thromb Hemost. 1994;20(1):64-70. doi: 10.1055/s-2007-1001890. Semin Thromb Hemost. 1994. PMID: 8059235 Review. No abstract available.
• Antiphospholipid antibodies and infertility: fact or fallacy.

  Ware Branch D, Hatasaka HH. Ware Branch D, et al. Lupus. 1998;7 Suppl 2:S90-4. doi: 10.1177/096120339800700220. Lupus. 1998. PMID: 9814681 Review.